Bu öğeden alıntı yapmak, öğeye bağlanmak için bu tanımlayıcıyı kullanınız: http://hdl.handle.net/11452/31275
Başlık: The efficacy of narrowband UVB treatment in pediatric vitiligo: A retrospective analysis of 26 cases
Yazarlar: Uludağ Üniversitesi/Tıp Fakültesi/Dermatoloji ve Venereoloji Anabilim Dalı.
0000-0001-6407-0962
0000-0002-0144-3263
Yazıcı, Serkan
Günay, Berrin
Başkan, Emel Bülbül
Aydoğan, Kenan
Sarıcaoğlu, Hayriye
Tunalı, Şükran
AAH-2459-2021
AAH-1388-2021
25925620000
57194115820
6602518817
9739755800
6603722836
7004191748
Anahtar kelimeler: General & internal medicine
Narrowband UVB
Pediatric
Phototherapy
Vitiligo
Generalized vitiligo
Children
Phototherapy
Childhood
Radiation
Yayın Tarihi: 10-Mar-2016
Yayıncı: TÜBİTAK
Atıf: Yazıcı, S. vd. (2017). ''The efficacy of narrowband UVB treatment in pediatric vitiligo: A retrospective analysis of 26 cases''. Turkish Journal of Medical Sciences, 47(2), 381-384.
Özet: Background/aim: Narrowband UVB (Nb UVB) treatment is commonly used for the management of psoriasis and atopic dermatitis, and is less often used for vitiligo in children. The aim of this study was to evaluate the efficacy and short-term safety of Nb UVB phototherapy in children diagnosed with vitiligo retrospectively Materials and methods: A total of 26 patients younger than 18 years with the diagnosis of vitiligo and managed with Nb UVB phototherapy as documented in archive records were evaluated. Clinical response was assessed according to repigmentation of the lesions: good response when there was more than 75% repigmentation, moderate response when there was 25%-74% repigmentation, poor response when repigmentation was less than 24%, and unresponsive when there was no pigmentation and new lesions occurred. Results: A total of 26 patients received Nb UVB treatment; 14 were girls and 12 were boys. The age at onset of the disease varied between 2 and 18 years, with a mean age of onset of 10.07 +/- 4.53 years. Repigmentation rate of > 75% was detected in 45.4% of cases. Conclusion: Nb UVB phototherapy seems to be a well-tolerated effective and safe treatment option in children, especially those unresponsive to topical treatment and those with widespread lesions. However, long-term risks such as photocarcinogenesis and photoaging should kept in mind.
URI: https://doi.org/10.3906/sag-1512-59
https://journals.tubitak.gov.tr/medical/vol47/iss2/2/
http://hdl.handle.net/11452/31275
ISSN: 1300-0144
1303-6165
Koleksiyonlarda Görünür:Scopus
TrDizin
Web of Science

Bu öğenin dosyaları:
Dosya Açıklama BoyutBiçim 
Yazıcı_vd_2017.pdf82.62 kBAdobe PDFKüçük resim
Göster/Aç


Bu öğe kapsamında lisanslı Creative Commons License Creative Commons